Crossmark

Fully automated, on-site isolation of cfDNA from whole blood for cancer therapy monitoring

Crossref DOI link: https://doi.org/10.1039/C8LC00165K

Published Online: 2018

Update policy: https://doi.org/10.1039/rsc_crossmark_policy

Authors

Kim, Chi-Ju

Park, Juhee

Sunkara, Vijaya

Kim, Tae-Hyeong

Lee, Yongjin

Lee, Kyusang

Kim, Mi-Hyun

Cho, Yoon-Kyoung https://orcid.org/0000-0001-6423-1834
Funding

Funding for this research was provided by:

Small and Medium Business Administration (S2334629)

Ministry of Health and Welfare (HI12C1845)
License Information

Accepted Manuscript valid from 2019-04-09
More Information

SIMILARITY CHECK

: This document is Similarity Check deposited

RELATED DATA

: Supplementary Information

IDENTIFIERS

: Yoon-Kyoung Cho (ORCID)

: Yoon-Kyoung Cho (ResearcherID)

PEER REVIEW METHOD

: Single-blind

PUBLICATION HISTORY

: Received 9 February 2018; Accepted 9 April 2018; Accepted Manuscript published 9 April 2018; Advance Article published 16 April 2018; Version of Record published 1 May 2018